Whitefort Capital Management, LP
Follow13F filer, CIK 1884931, NEW YORK, NY
Whitefort Capital Management, LP reported $212,532,764 across 15 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15. Its ten largest share positions make up 94.27% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-25-000674
- Period
- 2025-03-31
- Reported value
- $213M
- Holdings
- 15
- Top 10 weight
- 94.27%
- New
- 2
- Sold out
- 5
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| JOYYadded | +339,016 | $14.2M |
| ROIVadded | +1,020,000 | $10.3M |
| OABInew | +3,914,896 | $9.4M |
| VATEadded | +422,869 | $3.31M |
| ABUSadded | +66,051 | $231K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| EDRexited | -500,000 | -$15.6M |
| LQDAreduced | -937,065 | -$13.8M |
| NNexited | -629,590 | -$9.8M |
| NNAVWreduced | -53,616 | -$236K |
| OPKexited | -134,490 | -$198K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0001013594-25-000674, largest first. % of portfolio is the value over $212,532,764, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABUSARBUTUS BIOPHARMA CORP | 13,307,967 | $46.4M | 21.85% | +66,051 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 3,411,000 | $34.4M | 16.19% | +1,020,000 | Timeline | ||
| JOYYJOYY INC | 759,443 | $31.9M | 15% | +339,016 | Timeline | ||
| GNWGENWORTH FINL INC | 2,986,960 | $21.2M | 9.96% | 0 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 1,050,180 | $15.5M | 7.29% | -937,065 | Timeline | ||
| CDZICADIZ INC | 3,719,951 | $10.9M | 5.13% | 0 | Timeline | ||
| OABIOMNIAB INC | 3,914,896 | $9.4M | 4.42% | new | Timeline | ||
| GSLGLOBAL SHIP LEASE INC | 369,768 | $8.45M | 3.98% | 0 | Timeline | ||
| VATEINNOVATE CORP | 743,000 | $5.82M | 2.74% | +422,869 | Timeline | ||
| MAIDEN HOLDINGS LTDMAIDEN HOLDINGS LTD | 1,997,005 | $1.14M | 0.54% | 0 | |||
| NNAVWNEXTNAV INC | 47,264 | $208K | 0.1% | -53,616 | Timeline | ||
| TRIBTRINITY BIOTECH INVT LTD | 81,902 | $46.7K | 0.02% | 0 | Timeline |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| OPKO HEALTH INCOPKO HEALTH INC NOTE 3.750% 1/1 | principal | 9,350,000 | $15.1M | new |
| INNOVATE CORPINNOVATE CORP NOTE 7.500% 8/0 | principal | 12,218,000 | $7.11M | 0 |
| SABRE GLBL INCSABRE GLBL INC BOND | principal | 5,000,000 | $4.97M | 0 |
Sold out in Q1 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| EDRENDEAVOR GROUP HLDGS INC | 500,000 | $15.6M | shares |
| NNNEXTNAV INC | 629,590 | $9.8M | shares |
| Esperion Therapeutics IncEsperion Therapeutics Inc | 8,000,000 | $7.77M | principal |
| OPKOPKO HEALTH INC | 134,490 | $198K | shares |
| ALTENERGY ACQUISITION CORPALTENERGY ACQUISITION CORP | 186,315 | $783 | shares |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-25-000674 | base | 2025-05-15 | acceptance time not in the bulk data set |